MicroPort CardioFlow Medtech Corporation의 발행 주식은 몇 주인가요?
MicroPort CardioFlow Medtech Corporation의 총 발행 주식은 482.51주입니다.
주요 통계
이전 종가
$0.6465
시가
$0.29
일일 범위
$0.33 - $0.6465
52주 범위
$0.33 - $0.6465
거래량
800
평균 거래량
0
배당수익률
--
EPS(TTM)
-0.10
시가총액
$823.0M
MICROPORT CARDIOFLOW MEDTECH CO란 무엇인가요?
MicroPort CardioFlow Medtech Corp. operates as a holding company with interest in developing medical devices. The company is headquartered in Shanghai, Shanghai and currently employs 417 full-time employees. The company went IPO on 2021-02-04. The Company’s main business is engaged in the research and development and commercialization of transcatheter and surgical solutions for structural heart diseases. The Company’s pipelines include transcatheter aortic heart valve implantation (TAVI) series products, AnchorMan left atrial appendage closure (LAAC) product, transcatheter mitral valve (TMV) products, transcatheter tricuspid valve (TTV) products and procedural accessories. The firm conducts its business in the domestic and overseas markets.